|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 11.36 USD | +0.89% |
|
-2.24% | -44.20% |
| 09-08 | Keros Therapeutics Approves $5 Million Share Buyback | MT |
| 09-08 | Keros Therapeutics, Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.89% | -2.24% | +0.35% | +0.89% | -44.20% | -28.73% | -63.18% | -71.12% | - | 225M | |
| +4.16% | +3.04% | +6.84% | +34.82% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.16B | |
| -3.11% | -3.53% | -10.63% | -1.85% | +13.76% | +20.19% | +81.44% | +210.63% | +5,289.29% | 57.39B | |
| +0.89% | -0.63% | -2.82% | -1.50% | +5.17% | +2.17% | +36.19% | -18.64% | +203.27% | 47.64B | |
| +0.36% | +0.81% | -1.61% | +9.19% | +159.44% | +342.39% | +748.97% | +622.52% | - | 44.29B | |
| -0.96% | -4.50% | -3.57% | +24.72% | +14.55% | +24.96% | +31.45% | +8.23% | +227.72% | 42.5B | |
| -0.20% | -0.77% | -0.05% | +20.30% | +17.86% | +4.13% | +111.69% | +1.20% | +1,065.97% | 40.71B | |
| -0.54% | +2.93% | -2.41% | -0.54% | +5.93% | +9.31% | +50.41% | -10.44% | +144.22% | 30.97B | |
| -2.68% | +2.92% | +7.59% | +45.23% | +73.51% | +29.33% | +22.72% | -56.88% | - | 28.53B | |
| +0.05% | -1.64% | -6.61% | -0.66% | +1.79% | -8.14% | -12.10% | -61.07% | - | 24.34B | |
| +2.33% | -5.69% | -12.01% | -0.43% | -36.15% | -29.29% | +360.12% | +319.95% | +663.19% | 24.27B | |
| -2.42% | -0.88% | +2.73% | +20.79% | +11.35% | +7.48% | -6.70% | -18.11% | +97.64% | 20.32B | |
| +0.23% | -3.14% | +1.38% | +7.51% | +6.73% | +12.58% | +148.04% | +213.04% | +1,900.23% | 16.73B | |
| -0.43% | +0.87% | -13.70% | -7.36% | +174.96% | +131.18% | +339.91% | +1,692.64% | +637.33% | 15.16B | |
| +0.25% | +1.01% | -15.78% | -16.99% | - | - | - | - | - | 14.96B | |
| +0.43% | -3.23% | +1.91% | +7.93% | +19.97% | +19.01% | +43.96% | -29.30% | +81.88% | 14.63B | |
| +0.78% | +0.40% | -1.05% | +4.55% | +33.22% | +45.65% | +168.34% | +177.52% | +369.37% | 14.47B | |
| -3.04% | +1.11% | -4.95% | -5.37% | +20.40% | -15.90% | +500.76% | - | - | 14.38B | |
| +1.17% | -0.90% | +0.59% | +25.79% | +45.47% | +63.64% | +52.01% | -27.17% | +249.33% | 13.85B | |
| +0.17% | -9.86% | +18.59% | +27.14% | +29.77% | -16.40% | - | - | - | 13.83B | |
| Average | -0.08% | -1.39% | -1.76% | +9.71% | +33.59% | +34.89% | +150.46% | +174.27% | +910.79% | 27.67B | |
| Weighted average by Cap. | +0.09% | -1.23% | -1.68% | +12.57% | +41.34% | +46.88% | +155.51% | +146.63% | +1,300.28% |
- Stock Market
- Stocks
- KROS Stock
- Sector Keros Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
